Aerie Pharmaceuticals, Inc. announced the appointment of Ami Bavishi as Director, Investor Relations, reporting to Richard Rubino, Aerie’s Chief Financial Officer. Ms. Bavishi will drive all of Aerie’s investor relations activities, and joins Aerie from Burns McClellan, a public relations and investor relations firm with which Aerie will maintain an ongoing relationship. Aerie also announced the appointment of Vincent Santucci, Pharm.D., as Director, Scientific Market Access, reporting to Theresa Heah, M.D., M.B.A., Aerie’s Vice President of Clinical Research, Medical and Professional Affairs. Dr. Santucci previously held related positions at Sanofi Genzyme and Celgene.